As of 3:59pm ET
| +0.26 / +3.32%|
The 1 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +73.27% increase from the last price of 8.08.
The current consensus among 5 polled investment analysts is to Hold stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.